Memory B cell function in HIV-infected children-decreased memory B cells despite ART

Pediatric Research

Volumn 66, Issue 2, 2009, Pages 185-190

  Ghosh, Sujal ^a   Feyen, Oliver ^a   Jebran, Ahmad Fasel ^a   Huck, Kirsten ^a   Jetzek Zader, Martin ^a   Bas, Murat ^b   Niehues, Tim ^c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G; TETANUS ANTIBODY; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL FUNCTION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIPHTHERIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; LYMPHOCYTE TRANSFORMATION TEST; MEMORY CELL; PERTUSSIS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TETANUS; VIRUS LOAD; B LYMPHOCYTE; BLOOD; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; PATHOPHYSIOLOGY; VIROLOGY;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE SYSTEM PROCESSES; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; IMMUNOLOGIC MEMORY; VIRAL LOAD;

EID: 70349916366     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181aa057d     Document Type: Article

References (44)

1. 1. Amadori A, Zamarchi R, Ciminale V. Del Mistro A, Siervo S, Alberti A, Colombatti M, Chieco-Bianchi L 1989 HIV-1-specific B cell activation. A. major constituent of spontaneous B cell activation during HIV-I infection. J Immunol 143:2146-2152. (Pubitemid 19245179)
2. 2. Zamarchi R, Barelli A, Borri A, Petralia G, Omette L, Masiero S, Chieco-Bianchi L, Amadori A 2002 B cell activation, in peripheral blood and lymph nodes during HIV infection. AIDS 16:1217-1226. (Pubitemid 34666655)
3. Shirai A, Cosentino M, Leitman-KIinman SF, Klinman DM 1992 Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell, activation. J Clin Invest 89:561-566.
4. Martinez-Maza O, Breen EC 2002 B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol 14:528-532.
5. 5. Orulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Qarsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM 2000 B-eell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS 14:133-140. (Pubitemid 30116438)
6. De Milito A, Morch C, Sonnerborg A, Chiodi F 2001 Loss of memory (CD27) B lymphocytes in HIV-I infection. AIDS 15:957-964.
7. Chong Y, Ikematsu H, Kikuchi K, Yamamoto M, Murata M, Nishimura M, Nabeshima S, Kashiwagi S, Hayashi J 2004 Selective CD27+ (memory) B cell reduction and characteristic B cell alteration, in drug-naive and HAART-treated HIV type 1-.infected patients. AIDS Res Hum Retroviruses 20:219-226.
8. Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, Al BJ, Roos M, Lange JM, Danner SA, Goudsmit J, Schellekens PT 1988 Immunological abnormalities in human immunodeficiency virus (HlV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest 82:1908-1914.
9. 9. Conge AM, Tarte K, Reynes J, Segondy M, Gerfaux J, Zembala M, Vendrell JP 1998 Impairment of B-Iymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease. AIDS 12:1437-1449. (Pubitemid 28369643)
10. IRHIC 2004 Combined antiretroviral therapy reduces hyperimmunoglobulinemia in HIV-I infected children. AIDS 18:1423-1428.
11. Shearer WT, Easley KA, Goldfarb J, Rosenblatt HM, Jenson HB, Kovacs A, Mcintosh K 2000 Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children bom to HIV-1 women. The P(2)C(2) HIV Study Group. J Allergy Clin Immunol 106:559-566.
12. 12. Ibegbu C, Spira TJ, Nesheim S, Mendez H, Lee F, Polliotti B, Caba J, Nahmias A 1994 Subpopulations of T and B cells in perinatally HIV-infected and noninfected age-matched children compared with those in adults. Clin Immunol Immunopathol 71:27-32. (Pubitemid 24126595)
13. CDC 1.994 Revised classification system for human immunodeficiency virus infection in children less than 1.3 years of age. MMWR Morb Mortal Wkly Rep 43:1-10.
14. RKI 2008 Recommendation of the Standing Vaccination Commission, at Robert Koch Institute. Epidemiol Bull 30: 235-254.
15. Niehues T, Reichenbach J, Neubert J, Gudowius S, Puel A, Horneff G, Lainka E, Dirksen U, Schroten. H, Doffinger R, Casanova JL, Wahn V 2004 Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidi'otic ectodermal dysplasia. J Allergy Clin Immunol. 114:1456-1462.
16. Johnson AM, Whicher JT 2001 Effect of certified reference material 470 (CRM 470) on national quality assurance programs for serum proteins in Europe. Clin Chem. Lab Med 39:1123-1128.
17. 17. Niehues T, Rocha V, Filrpovich AH, Chan KW, Porcher R, Michel G, Ortega JJ, Wemel P, Gobel U, Gluckman E, Locatelli F 2001 Factors affecting lymphocyte subset reconstitution after either related or unrelated cold blood transplantation in children-a Eurocord analysis. Br J Haematol 114:42-48. (Pubitemid 32702631)
18. 18. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, Wara DW, Douglas SD, Luzuriaga K, McFarland EJ, Yogev R, Rathore MH, Levy W, Graham BL, Spector SA 2003 Lymphocyte subsets in healthy children, from birth through 1.8 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 112:973-980. (Pubitemid 37412068)
19. Kam KM, Leung WL, Wong KH, Lee SS, Hung MY, Kwok MY 2001 Maturational changes in peripheral lymphocyte subsets pertinent to monitoring human immunodeficiency virus-infected Chinese pediatric patients. Clin Diagn Lab Immunol 8:926-931.
20. 20. Rodriguez C, Thomas JK, O'Rourke S, Stiehm. ER, Plaeger S 1996 HIV disease in children is associated with a selective decrease in CD23 + and CD62L- B cells. Clin Immunol Immunopathol 81:.191-199. (Pubitemid 26393664)
21. 21. Kansas GS, Dailey MO 1989 Expression, of adhesion structures during B cell development in man. J Immunol 142:3058-3062. (Pubitemid 19129922)
22. LeBien TW 2000 Fates of human B-cell precursors. Blood 96:9-23.
23. Malaspina A, Moir S, Nickle DC, Donoghue ET, Ogwaro KM, Ehler LA, Liu S, Mican JA, Dybul M, Chun TW, Mullins JI, Fauci AS 2002 Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasma. J Virol 76:8855-8863.
24. 24. Forster R, Schweigard G, Johann S, Emrich T, Kremmer E, Nerl C, Lipp M 1997 Abnormal expression of the B-cell homing chemokine receptor BLRl during the progression of acquired immunodeficiency syndrome. Blood 90:520-525. (Pubitemid 27299090)
25. Jinquan T, Moller B, Storgaard M, Mukaida N, Bonde J, Grunnet N, Black FT, Larsen CG, Matsushima K, Thestrup-Pedersen K 1997 Chemotaxis and IL-S receptor expression in B cells from normal and HIV-infected subjects. J Immunol 158:475-484.
26. Nagase H, Agematsu K, Kitano K, Takamoto M, Okubo Y, Komiyama A, Sugane K 2001 Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis. Clin Immunol 100:250-259.
27. D'Orsogna LJ, Krueger RG, McKinnon EJ, French MA 2007 Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy. AIDS 21:1747-1752.
28. Nagumo H, Agematsu K, Shinozaki K, Hokibara S, Ito S, Takamoto M, Nikaido T, Yasui K, Uehara Y, Yachie A, Komiyama A 1998 CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J Immunol 161:6496-6502.
29. de Martino M, Tovo PA, Galli L, Gabiano C, Cozzani S, Gotta C, Scarlatti G, Fiocchi A, Cocchi P, Marchisio P, Canino R, Mautone A, Chiappe F, Campelli A, Consolini R, Izzi G, Laverda A, Alberti S, Tozzi AE, Duse M 1991 Prognostic significance of immunologie changes in 675 infants perinatally exposed to human immunodeficiency virus. The Italian Register for Human Immunodeficiency Virus Infection in Children. J Pediatr 119:702-709.
30. Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, Krishnan. SR, Planta MA, Turney JF, Justement JS, Kottilil S, Dybul M, Mican JM, Kovacs C, Chun TW, Birse CE, Fauci AS 2004 Decreased survival, of B cells of HI V-viremic patients mediated by altered expression of receptors of the TNF supeifamily. J Exp Med 200:587-599.
31. 31. Samuelsson A, Sonnerborg A, Heuts N, Coster J, Chiodi F 1997 Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection. AIDS Res Hum. Retroviruses 13:1031-1038. (Pubitemid 27330090)
32. Titanji K, Chiodi. F, Bellocco R, Schepis D, Osorio L, Tassandin C, Tambussi G, Qrutzmeier S, Lopalco L, De Milito A 2005 Primary HIV-I infection sets the stage for important B lymphocyte dysfunctions. AIDS 19:1947-1955.
33. Malaspina A, Moir S, Ho J, Wang W, Howell ML, O'Shea MA, Roby GA, Rehm CA, Mican. JM, Chun TW, Fauci. AS 2006 Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci USA 103:2262-2267.
34. 34. Malaspina A, Moir S, Chaitt DG, Rehm CA, Kottilil S, Falloon J, Fauci AS 2007 Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/ transitional B cells and serum levels of IL-7. Blood 109:2086-2088. (Pubitemid 46348209)
35. Moir S, Fauci AS 2008 Pathogenic mechanisms of B-lymphocyle dysfunction in HIV disease. J Allergy Clin Immunol 1.22:1.2-1.9; quiz 20-21.
36. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O'Shea MA, Roby G, Kottilil S, Arthos J, Proschan MA, Chun. TW, Fauci AS 2008 Evidence for HlV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205:1797-1805.
37. Moir S, Malaspina A, Ho J, Wang W, Dipoto AC, O'Shea MA, Roby G, Mican JM, Kottilil S, Chun TW, Proschan MA, Fauci AS 2008 Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. J Infect Dis 197:572-579.
38. 38. Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomao R, Kallas EG, de Moraes-Pinto MI 2007 HIV-1-.infected children on HAART: immunologic features of three different levels of viral suppression. Cytometry B Clin Cytom 72:14-21. (Pubitemid 46105453)
39. Rosenblatt HM, Song LY, Nachman SA, Stanley KE, Krogstad PA, Johnson GM, Wiznia AA. 2005 Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection. J Allergy Clin. Immunol 116:698-703.
40. 40. Arpadi SM, Markowitz LE, Baughman AL, Shah K, Adam H, Wiznia A, Lambert G, Dobroszycki J, Heath JL, Bellini WJ 1996 Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics 97:653-657. (Pubitemid 26138094)
41. 41. Berkelhamer S, Borock E, Elsen C, Englund J, Johnson D 2001 Effect of highly active antiretroviral, therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children. Clin Infect Dis 32:1090-1094. (Pubitemid 32299645)
42. 42. Levin MJ, Gershon AA, Weinberg A, Blanchard S, Nowak B, Palumbo P, Chan CY 2001 Immunization of HIV-infected children with, varicella vaccine. J Pediatr 139:305-310. (Pubitemid 32721722)
43. 43. Lima M, De Menezes Succi RC, Nunes Dos Santos AM, Weckx LY, De MoraesPinto MI 2004 Rubella immunization in human immunodeficiency virus type 1-infected children: cause for concern in vaccination, strategies. Pediatr Infect Dis J 23:604-607. (Pubitemid 38924882)
44. Melvin AJ, Mohan KM 2003 Response to immunization with measles, tetanus, and Haemophilus Influenzae type b vaccines in children who have human immunodeficiency virus type I. infection and are treated with highly active antiretroviral, therapy. Pediatrics 111:e641-e644.